Finnrick - Ensuring a Safer and More Transparent Supply Chain
Evolve BioPep

Evolve BioPep

Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Evolve BioPep between 2 Jul 2025 and 30 Oct 2025. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).

Finnrick Rating™
Tentative Rating
Evolve BioPep
Tirzepatide
Tested 4 Samples
Last test 30 Oct 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Evolve BioPep

Samples are tested in commercial labs

Tests Count

4

Scores

AVG6.2MIN5.2MAX8.0

Last

30 Oct 2025

First

2 Jul 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
30 Oct 2025View6.130mg33.500mg+11.7%99.90%(no batch ID)No Label / Copper Crimp / Clear CapLab GPublic
9 Oct 2025View8.040mg41.000mg+2.5%99.94%(no batch ID)No Label / Silver Crimp / Green Cap Lab EPublic
18 Sep 2025View5.730mg25.700mg-14.3%99.88%(no batch ID)White Label / Silver Crimp / Orange Cap Lab EPublic
2 Jul 2025View5.230mg28.100mg-6.3%98.66%(no batch ID)White Label / Silver Crimp / Black Cap Lab EPublic